← Back to Clinical Trials
Recruiting NCT07750795

NCT07750795 Nutrition and Physical Activity Education in Children With Celiac Disease

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07750795
Status Recruiting
Phase —
Sponsor Bahçeşehir University
Condition Celiac Disease
Study Type INTERVENTIONAL
Enrollment 54 participants
Start Date 2026-05-01
Primary Completion 2027-01-01

Eligibility & Interventions

Sex All sexes
Min Age 8 Years
Max Age 12 Years
Study Type INTERVENTIONAL
Interventions
Nutrition EducationPhysical Activity Education

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 54 participants in total. It began in 2026-05-01 with a primary completion date of 2027-01-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Celiac disease is a chronic immune-mediated disorder that requires lifelong adherence to a gluten-free diet. Despite dietary treatment, children with celiac disease may experience nutritional inadequacies, unhealthy eating behaviors, reduced physical activity, and impaired quality of life. This randomized, single-blind, controlled trial aims to evaluate the effects of a structured nutrition education program combined with physical activity education on anthropometric measurements, eating behavior, physical activity, and health-related quality of life in children aged 8-12 years with celiac disease. Fifty-four participants will be randomly assigned to one of three groups: (1) nutrition and physical activity education, (2) physical activity education only, or (3) no education (control). Outcomes will be assessed at baseline and after a 6-week follow-up using validated questionnaires, anthropometric measurements, body composition analysis, and physical performance tests. The findings are expected to provide evidence for multidisciplinary educational interventions to improve the health and well-being of children with celiac disease.

Eligibility Criteria

Inclusion Criteria Children aged 8 to 12 years (inclusive). Clinically diagnosed with celiac disease. Following a gluten-free diet for at least 6 months before enrollment. Able to understand study instructions and complete study assessments. Parent or legal guardian able to provide written informed consent. Child able to provide assent to participate. Exclusion Criteria Following a gluten-free diet for reasons other than celiac disease. Age younger than 8 years or older than 12 years. Refusal or inability of the parent/legal guardian to provide informed consent or of the child to provide assent. Any physical disability or medical condition that would limit participation in the physical activity program.

Contact & Investigator

Central Contact

İlayda Altuncevahir, Assistant Professor, PhD

✉ ilayda.altuncevahir@bau.edu.tr

📞 +90 530 110 5045

Frequently Asked Questions

Who can join the NCT07750795 clinical trial?

This trial is open to participants of all sexes, aged 8 Years or older, up to 12 Years, studying Celiac Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07750795 currently recruiting?

Yes, NCT07750795 is actively recruiting participants. Contact the research team at ilayda.altuncevahir@bau.edu.tr for enrollment information.

Where is the NCT07750795 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT07750795 clinical trial?

NCT07750795 is sponsored by Bahçeşehir University. The trial plans to enroll 54 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology